1Palaniappan L, Carnethon M, Fortmann SP, et al. Association between microalbuminuria and the metabolic syndrome: NHANES Ⅲ . Am J Hypertens, 2003,16(11 Pt 1): 952
2Rowley KG, Iser DM, Best JD, et al. Albuminuria in Australian Aboriginal people: prevalence and associations with components of the metabolic syndrome. Diabetologia,2000,43( 11 ): 1397
3Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med, 2004,140(3):167
4Jeffrey R, Henegar SA, Bigler LK. Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol, 2001,12:1211
6Praga M, Hernandez E, Morales E, et al. Clinical features and long-term outcome of obesity-associated focal segmental glomemlosclerosis. Nephrol Dial Transplant,2001, 16(9): 1790
7Bonnet F, Deprele C, Sassolas A, et al. Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am J Kidney Dis,2001, 37(4): 720
8Alebiosu CO. An update on ‘progression promoters' in renal diseases. J Natl Med Assoc,2003,95( 1 ) :30
9Salahudeen AK. Obesity and survival on dialysis. Am J Kidney Dis,2003,41 (5) :925
10Salahudeen A K. Is it really good to be fat on dialysis? Nephrol Dial Transplant, 2003,18:1248
9Isomaa B,Henricsson M,Almgren P,et al.The metabolic syndrome influence the risk of chronic complications in patients with type Ⅱ diabetes.Diabetologia,2001,24(4):683-689.
10Costa LA,Canani LH,Lisboa HR,et al.Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in Type 2 diabetes.Diabet Med,2004,21(3):252-255.
